News

Video

The Impact of Congenital Plasminogen Deficiency on the Gynecologic System

Per Morten Sandset, MD, of the University of Oslo and Oslo University Hospital, discusses the disease impact on the gynecologic system and how often patients become infertile due to this impact.

Pharmacy Times® interviewed Per Morten Sandset, MD, a principal investigator and professor in the Department of Haematology and the Research Institute of Internal Medicine at the University of Oslo and Oslo University Hospital, on his presentation at the 62nd ASH Annual Meeting and Exposition. The presentation discusses research conducted to investigate the successful pregnancy of a patient with infertility due to congenital plasminogen deficiency who was treated with intravenous plasminogen replacement therapy.

In this video, Sandset discusses the disease impact on the gynecologic system and how often patients become infertile due to this impact.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Image credit: Sebastian Kaulitzki | stock.adobe.com
Magnified bone marrow biopsy showing plasma cells with irregular nuclei and multiple myeloma tumor cells infiltrating normal hematopoietic tissue
Image credit: Dr_Microbe | stock.adobe.com